International Screening Limits in plasma and signatory countries in the Asian region


Updated 21 September 2017

Drug ISL in Plasma (ng/ml) Codes of Signatory Countries#
Butorphanol 0.01 AU, HK, KR, MU, SG, TH, ZA
Carprofen 100.0 AU, HK, JP, KR, MU, SG, TH, ZA
Dembrexine 5.0 HK, SG, KR, MU, TH, ZA
Flunixin 1.0 AU, HK, JP, SG, KR, MU, TH, ZA
Furosemide 0.1 AU, HK, JP, SG, KR, MU, TH, ZA
Phenylbutazone 100.0 AU, HK, JP, KR, MU, SG, TH
Lidocaine 0.05 AU, HK, JP, KR, MU, SG, TH, ZA
Mepivacaine 0.05 AU, HK, KR, MU, SG, TH, ZA
Acepromazine 0.02 AU, HK, JP, KR, MU, SG, TH, ZA
N-Butylscopolammonium 0.05 AU, HK, KR, SG, TH, ZA
Detomidine 0.02 ng/mL of 3’-hydroxydetomidine AU, HK, JP, KR, MU, SG, TH, ZA
Meclofenamic Acid 5.0 AU, HK, JP, KR, MU, SG, TH, ZA
Meloxicam 1.0 AU, HK, JP, MY, MU, VN, ZA
Medetomidine 0.02 ng/mL of 3'-hydroxymedetomidine AU, HK, JP, MU


'# Signatory countries in Asia that have adopted the individual ISL in plasma.

ARF Country codes: AU = Australia; BH = Bahrain; HK = Hong Kong; IN = India; JP = Japan; KR = Korea; MO = Macau; MY = Malaysia; MU = Mauritius; MN = Mongolia; NZ = New Zealand; OM = Oman; PK = Pakistan; PH = Philippines; QA = Qatar; SA = Saudi Arabia; SG = Singapore; ZA = South Africa; TH = Thailand; TM = Turkmenistan; TR = Turkey; AE = United Arab Emirates; VN = Vietnam.